Pharmacokinetics and safety of lamotrigine (Lamictal®) in patients with epilepsy
- 31 December 1991
- journal article
- clinical trial
- Published by Elsevier
- Vol. 10 (2) , 191-200
- https://doi.org/10.1016/0920-1211(91)90012-5
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsyEpilepsy Research, 1989
- Lamotrigine, a new anticonvulsant: Pharmacokinetics in normal humansClinical Pharmacology & Therapeutics, 1987
- Comparison of a GLC-NPD Method with a GLC-MS-SIM Procedure for the Determination of Tilidine and Its Metabolites in PlasmaJournal of Analytical Toxicology, 1987
- Seven day administration of lamotrigine in epilepsy: placebocontrolled add-on trialEpilepsy Research, 1987
- Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsyEpilepsy Research, 1987
- The effect of lamotrigine, a novel anticonvulsant, on interictal spikes in patients with epilepsy.British Journal of Clinical Pharmacology, 1986
- Acute Effects of Lamotrigine (BW430C) in Persons With EpilepsyEpilepsia, 1986
- Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam.British Journal of Clinical Pharmacology, 1985
- Noncompartmental Determination of the Steady‐State Volume of DistributionJournal of Pharmaceutical Sciences, 1979
- EFFECTS ON THE HUMAN CENTRAL NERVOUS SYSTEM OF TWO ISOMERS OF EPHEDRINE AND TRIPROLIDINE, AND THEIR INTERACTIONBritish Journal of Clinical Pharmacology, 1974